相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Disarming Staphylococcus aureus from destroying human cells by simultaneously neutralizing six cytotoxins with two human monoclonal antibodies
Harald Rouha et al.
VIRULENCE (2018)
Safety and tolerability of a single administration of AR-301, a human monoclonal antibody, in ICU patients with severe pneumonia caused by Staphylococcus aureus: first-in-human trial
Bruno Francois et al.
INTENSIVE CARE MEDICINE (2018)
Molecular mechanisms of action of sphingomyelin-specific pore-forming toxin, lysenin
Neval Yilmaz et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2018)
Broad-Spectrum Neutralization of Pore-Forming Toxins with Human Erythrocyte Membrane-Coated Nanosponges
Yijie Chen et al.
ADVANCED HEALTHCARE MATERIALS (2018)
Safety, Tolerability, and Pharmacokinetics of MEDI4893, an Investigational, Extended-Half-Life, Anti-Staphylococcus aureus Alpha-Toxin Human Monoclonal Antibody, in Healthy Adults
Xiang-Qing Yu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
DNA-assisted oligomerization of pore-forming toxin monomers into precisely-controlled protein channels
Anja Henning-Knechtel et al.
NUCLEIC ACIDS RESEARCH (2017)
Staphylococcus aureus pore-forming toxins: The interface of pathogen and host complexity
E. Sachiko Seilie et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2017)
CryoEM structures of membrane pore and prepore complex reveal cytolytic mechanism of Pneumolysin
Katharine van Pee et al.
ELIFE (2017)
A Red Blood Cell Membrane-Camouflaged Nanoparticle Counteracts Streptolysin O-Mediated Virulence Phenotypes of Invasive Group A Streptococcus
Tamara Escajadillo et al.
Frontiers in Pharmacology (2017)
Serum and Lung Pharmacokinetics of ASN100, a Monoclonal Antibody Combination for the Prevention and Treatment of Staphylococcus aureus Pneumonia
Zoltan Magyarics et al.
Open Forum Infectious Diseases (2017)
Molecular docking based screening of Listeriolysin-O for improved inhibitors
Sara Ghafari et al.
BIOINFORMATION (2017)
Self-Assembled Colloidal Gel Using Cell Membrane-Coated Nanosponges as Building Blocks
Yue Zhang et al.
ACS NANO (2017)
Intrinsic repair protects cells from pore-forming toxins by microvesicle shedding
Matthew Romero et al.
CELL DEATH AND DIFFERENTIATION (2017)
Anticytotoxin Effects of Amentoflavone to Pneumolysin
Xiaoran Zhao et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2017)
Pore-forming toxins: ancient, but never really out of fashion
Matteo Dal Peraro et al.
NATURE REVIEWS MICROBIOLOGY (2016)
Inhibiting bacterial toxins by channel blockage
Sergey M. Bezrukov et al.
PATHOGENS AND DISEASE (2016)
Apigenin protects mice from pneumococcal pneumonia by inhibiting the cytolytic activity of pneumolysin
Meng Song et al.
FITOTERAPIA (2016)
Protective efficacy of a novel alpha hemolysin subunit vaccine (AT62) against Staphylococcus aureus skin and soft tissue infections
Rajan P. Adhikari et al.
VACCINE (2016)
Cryo-EM structure of aerolysin variants reveals a novel protein fold and the pore-formation process
Ioan Iacovache et al.
Nature Communications (2016)
Disentangling the roles of cholesterol and CD59 in intermedilysin pore formation
Courtney M. Boyd et al.
SCIENTIFIC REPORTS (2016)
Verbascoside Alleviates Pneumococcal Pneumonia by Reducing Pneumolysin Oligomers
Xiaoran Zhao et al.
MOLECULAR PHARMACOLOGY (2016)
Inhibition of the hemolytic activity caused by Staphylococcus aureus alpha-hemolysin through isatin-Schiff copper(II) complexes
Maria C. A. Melo et al.
FEMS MICROBIOLOGY LETTERS (2016)
How Lipid Membranes Affect Pore Forming Toxin Activity
Nejc Rojko et al.
ACCOUNTS OF CHEMICAL RESEARCH (2015)
Statin-Conferred Enhanced Cellular Resistance against Bacterial Pore-Forming Toxins in Airway Epithelial Cells
Sarah Statt et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2015)
MEDI4893(star) Promotes Survival and Extends the Antibiotic Treatment Window in a Staphylococcus aureus Immunocompromised Pneumonia Model
L. Hua et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Antibacterial monoclonal antibodies: the next generation?
Antonio DiGiandomenico et al.
CURRENT OPINION IN MICROBIOLOGY (2015)
Morin hydrate attenuates Staphylococcus aureus virulence by inhibiting the self-assembly of α-hemolysin
J. Wang et al.
JOURNAL OF APPLIED MICROBIOLOGY (2015)
X-ray and Cryo-electron Microscopy Structures of Monalysin Pore-forming Toxin Reveal Multimerization of the Pro-form
Philippe Leone et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
More Than a Pore: The Interplay of Pore-Forming Proteins and Lipid Membranes
Uris Ros et al.
JOURNAL OF MEMBRANE BIOLOGY (2015)
Directly Observing the Lipid-Dependent Self-Assembly and Pore-Forming Mechanism of the Cytolytic Toxin Listeriolysin O
Estefania Mulvihill et al.
NANO LETTERS (2015)
The adherens junctions control susceptibility to Staphylococcus aureus α-toxin
Lauren M. Popov et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Interactions between Autophagy and Bacterial Toxins: Targets for Therapy?
Jacques Mathieu
TOXINS (2015)
Biological Effects of Listeriolysin O: Implications for Vaccination
K. G. Hernandez-Flores et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Streptolysin O Rapidly Impairs Neutrophil Oxidative Burst and Antibacterial Responses to Group A Streptococcus
Satoshi Uchiyama et al.
FRONTIERS IN IMMUNOLOGY (2015)
Red wines and flavonoids diminish Staphylococcus aureus virulence with anti-biofilm and anti-hemolytic activities
Hyun Seob Cho et al.
BIOFOULING (2015)
Fisetin Inhibits Listeria monocytogenes Virulence by Interfering With the Oligomerization of Listeriolysin O
Jianfeng Wang et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
Five birds, one stone: Neutralization of alpha-hemolysin and 4 bi-component leukocidins of Staphylococcus aureus with a single human monoclonal antibody
Harald Rouha et al.
MABS (2015)
Engineered liposomes sequester bacterial exotoxins and protect from severe invasive infections in mice
Brian D. Henry et al.
NATURE BIOTECHNOLOGY (2015)
β-sitosterol interacts with pneumolysin to prevent Streptococcus pneumoniae infection
Hongen Li et al.
SCIENTIFIC REPORTS (2015)
Assessment of an Anti-Alpha-Toxin Monoclonal Antibody for Prevention and Treatment of Staphylococcus aureus-Induced Pneumonia
L. Hua et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Inhibition of Pore Formation by Blocking the Assembly of Staphylococcus aureus α-Hemolysin Through a Novel Peptide Inhibitor: an In Silco Approach
Nidhi Rani et al.
INTERNATIONAL JOURNAL OF PEPTIDE RESEARCH AND THERAPEUTICS (2014)
Rapid Degradation of the Complement Regulator, CD59, by a Novel Inhibitor
Bishuang Cai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Mechanisms of Neutralization of a Human Anti-α-toxin Antibody
Vaheh Oganesyan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Broadly Protective Protein-Based Pneumococcal Vaccine Composed of Pneumolysin Toxoid-CbpA Peptide Recombinant Fusion Protein
Beth Mann et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
Targeting Staphylococcus aureus α-Toxin as a Novel Approach to Reduce Severity of Recurrent Skin and Soft-Tissue Infections
Georgia R. Sampedro et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
The Bicomponent Pore-Forming Leucocidins of Staphylococcus aureus
Francis Alonzo et al.
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2014)
The cholesterol-dependent cytolysins pneumolysin and streptolysin O require binding to red blood cell glycans for hemolytic activity
Lucy K. Shewell et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Safety, reactogenicity and immunogenicity of a novel pneumococcal protein-based vaccine in adults: A phase I/II randomized clinical study
Geert Leroux-Roels et al.
VACCINE (2014)
Safety and immunogenicity of an investigational vaccine containing two common pneumococcal proteins in toddlers: A phase II randomized clinical trial
Roman Prymula et al.
VACCINE (2014)
Clostridium perfringens epsilon toxin mutant Y30A-Y196A as a recombinant vaccine candidate against enterotoxemia
Monika Bokori-Brown et al.
VACCINE (2014)
Staphylococcus aureus Leukotoxin ED Targets the Chemokine Receptors CXCR1 and CXCR2 to Kill Leukocytes and Promote Infection
Tamara Reyes-Robles et al.
CELL HOST & MICROBE (2013)
Autophagy and bacterial clearance: a not so clear picture
Serge Mostowy
CELLULAR MICROBIOLOGY (2013)
Role of Pore-Forming Toxins in Neonatal Sepsis
Andreas F. -P. Sonnen et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2013)
Membrane Damage by an α-Helical Pore-forming Protein, Equinatoxin II, Proceeds through a Succession of Ordered Steps
Nejc Rojko et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Mechanism of Action and In Vivo Efficacy of a Human-Derived Antibody against Staphylococcus aureus α-Hemolysin
Davide Folettit et al.
JOURNAL OF MOLECULAR BIOLOGY (2013)
CCR5 is a receptor for Staphylococcus aureus leukotoxin ED
Francis Alonzo et al.
NATURE (2013)
Nanoparticle-detained toxins for safe and effective vaccination
Che-Ming J. Hu et al.
NATURE NANOTECHNOLOGY (2013)
A biomimetic nanosponge that absorbs pore-forming toxins
Che-Ming J. Hu et al.
NATURE NANOTECHNOLOGY (2013)
Role of Pore-Forming Toxins in Bacterial Infectious Diseases
Ferdinand C. O. Los et al.
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2013)
Structurally Designed Attenuated Subunit Vaccines for S. aureus LukS-PV and LukF-PV Confer Protection in a Mouse Bacteremia Model
Hatice Karauzum et al.
PLOS ONE (2013)
Evaluation of the Protective Immunity of a Novel Subunit Fusion Vaccine in a Murine Model of Systemic MRSA Infection
Qian-Fei Zuo et al.
PLOS ONE (2013)
Clostridium perfringens epsilon toxin H149A mutant as a platform for receptor binding studies
Monika Bokori-Brown et al.
PROTEIN SCIENCE (2013)
Targeted Amino Acid Substitutions Impair Streptolysin O Toxicity and Group A Streptococcus Virulence
Emiliano Chiarot et al.
MBIO (2013)
Structural Basis for Recognition of the Pore-Forming Toxin Intermedilysin by Human Complement Receptor CD59
Steven Johnson et al.
CELL REPORTS (2013)
Oroxylin A Inhibits Hemolysis via Hindering the Self-Assembly of α-Hemolysin Heptameric Transmembrane Pore
Jing Dong et al.
PLOS COMPUTATIONAL BIOLOGY (2013)
Mini-Review: Novel Therapeutic Strategies to Blunt Actions of Pneumolysin in the Lungs
Rudolf Lucas et al.
TOXINS (2013)
More Than a Pore: The Cellular Response to Cholesterol-Dependent Cytolysins
Sara K. B. Cassidy et al.
TOXINS (2013)
Pathogenic Pore-Forming Proteins: Function and Host Response
Mirko Bischofberger et al.
CELL HOST & MICROBE (2012)
Obstructing Toxin Pathways by Targeted Pore Blockage
Ekaterina M. Nestorovich et al.
CHEMICAL REVIEWS (2012)
Identification of Anti-Alpha Toxin Monoclonal Antibodies That Reduce the Severity of Staphylococcus aureus Dermonecrosis and Exhibit a Correlation between Affinity and Potency
C. Tkaczyk et al.
CLINICAL AND VACCINE IMMUNOLOGY (2012)
Baicalin Protects Mice From Staphylococcus aureus Pneumonia Via Inhibition of the Cytolytic Activity of α-Hemolysin
Jiazhang Qiu et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
Genetic Requirement for ADAM10 in Severe Staphylococcus aureus Skin Infection
Naoko Inoshima et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2012)
A new pharmacological agent (AKB-4924) stabilizes hypoxia inducible factor-1 (HIF-1) and increases skin innate defenses against bacterial infection
Cheryl Y. M. Okumura et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2012)
Listeriolysin O Is Strongly Immunogenic Independently of Its Cytotoxic Activity
Javier A. Carrero et al.
PLOS ONE (2012)
Novel Structurally Designed Vaccine for S. aureus α-Hemolysin: Protection against Bacteremia and Pneumonia
Rajan P. Adhikari et al.
PLOS ONE (2012)
Correction: The Cholesterol-Dependent Cytolysin Signature Motif: A Critical Element in the Allosteric Pathway that Couples Membrane Binding to Pore Assembly
Kelley J. Dowd et al.
PLoS Pathogens (2012)
Symmetry Requirements for Effective Blocking of Pore-Forming Toxins: Comparative Study with α-, β-, and γ-Cyclodextrin Derivatives
Konstantina Yannakopoulou et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Streptolysin O clearance through sequestration into blebs that bud passively from the plasma membrane
Peter A. Keyel et al.
JOURNAL OF CELL SCIENCE (2011)
Gene-Trap Mutagenesis Identifies Mammalian Genes Contributing to Intoxication by Clostridium perfringens ε-Toxin
Susan E. Ivie et al.
PLOS ONE (2011)
Heavy chain-only antibodies and tetravalent bispecific antibody neutralizing Staphylococcus aureus leukotoxins
Benoit-Joseph Laventie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform
Che-Ming J. Hu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Characterization of the interactions of the pneumolysoid, Δ6 PLY, with human neutrophils in vitro
R. Cockeran et al.
VACCINE (2011)
A protein-based pneumococcal vaccine protects rhesus macaques from pneumonia after experimental infection with Streptococcus pneumoniae
Philippe Denoel et al.
VACCINE (2011)
Global Functional Analyses of Cellular Responses to Pore-Forming Toxins
Cheng-Yuan Kao et al.
PLOS PATHOGENS (2011)
Poly(ethylene glycol) in Drug Delivery: Pros and Cons as Well as Potential Alternatives
Katrin Knop et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2010)
Prevention and Treatment of Staphylococcus aureus Pneumonia with a beta-Cyclodextrin Derivative
Brook E. Ragle et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Applications of biological pores in nanomedicine, sensing, and nanoelectronics
Sheereen Majd et al.
CURRENT OPINION IN BIOTECHNOLOGY (2010)
Factors that Control the Circulation Time of Nanoparticles in Blood: Challenges, Solutions and Future Prospects
Jin-Wook Yoo et al.
CURRENT PHARMACEUTICAL DESIGN (2010)
Invasive pneumococcal disease after implementation of a reduced three-dose pneumococcal conjugate vaccine program: a pediatric tertiary care center experience
Pierre Alex Crisinel et al.
EUROPEAN JOURNAL OF PEDIATRICS (2010)
Statins protect against fulminant pneumococcal infection and cytolysin toxicity in a mouse model of sickle cell disease
Jason W. Rosch et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Targeting of Alpha-Hemolysin by Active or Passive Immunization Decreases Severity of USA300 Skin Infection in a Mouse Model
Adam D. Kennedy et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Inhibition of streptolysin O by allicin - an active component of garlic
Mohsen Arzanlou et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2010)
Expression of two Listeria monocytogenes antigens (P60 and LLO) in Lactococcus lactis and examination for use as live vaccine vectors
Mohammed Bahey-El-Din et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2010)
Anti-virulence strategies to combat bacteria-mediated disease
David A. Rasko et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Subinhibitory Concentrations of Thymol Reduce Enterotoxins A and B and α-Hemolysin Production in Staphylococcus aureus Isolates
Jiazhang Qiu et al.
PLOS ONE (2010)
Only two amino acids are essential for cytolytic toxin recognition of cholesterol at the membrane surface
Allison J. Farrand et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Role of a disintegrin and metalloprotease 10 in Staphylococcus aureus α-hemolysin-mediated cellular injury
Georgia A. Wilke et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Oxygen homeostasis
Gregg L. Semenza
WILEY INTERDISCIPLINARY REVIEWS-SYSTEMS BIOLOGY AND MEDICINE (2010)
Identification of Small Molecule Inhibitors of Clostridium perfringens ε-Toxin Cytotoxicity Using a Cell-Based High-Throughput Screen
Michelle Lewis et al.
TOXINS (2010)
Therapeutic antibodies: successes, limitations and hopes for the future
Patrick Chames et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
Helen W. Boucher et al.
CLINICAL INFECTIOUS DISEASES (2009)
Autophagy: Regulation and role in disease
Alfred J. Meijer et al.
CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES (2009)
Membrane injury by pore-forming proteins
Mirko Bischofberger et al.
CURRENT OPINION IN CELL BIOLOGY (2009)
Anti-Alpha-Hemolysin Monoclonal Antibodies Mediate Protection against Staphylococcus aureus Pneumonia
Brook E. Ragle et al.
INFECTION AND IMMUNITY (2009)
Intermedilysin-Receptor Interactions during Assembly of the Pore Complex ASSEMBLY INTERMEDIATES INCREASE HOST CELL SUSCEPTIBILITY TO COMPLEMENT-MEDIATED LYSIS
Stephanie LaChapelle et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Haploid Genetic Screens in Human Cells Identify Host Factors Used by Pathogens
Jan E. Carette et al.
SCIENCE (2009)
Hypoxia and the Hypoxic Response Pathway Protect against Pore-Forming Toxins in C. elegans
Audrey Bellier et al.
PLOS PATHOGENS (2009)
Pore formation: An ancient yet complex form of attack
Ioan Iacovache et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2008)
Passive administration of monoclonal antibodies to Anthrolysin O prolong survival in mice lethally infected with Bacillus anthracis
Antonio Nakouzi et al.
BMC MICROBIOLOGY (2008)
The epidemic of antibiotic-resistant infections: A call to action for the medical community from the Infectious Diseases Society of America
Brad Spellberg et al.
CLINICAL INFECTIOUS DISEASES (2008)
Vaccine protection against Staphylococcus aureus pneumonia
Juliane Bubeck Wardenburg et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Factors affecting the clearance and biodistribution of polymeric nanoparticles
Frank Alexis et al.
MOLECULAR PHARMACEUTICS (2008)
Interferons increase cell resistance to staphylococcal alpha-toxin
Timur O. Yarovinsky et al.
INFECTION AND IMMUNITY (2008)
The polyphenol (-)-epicatechin gallate disrupts the secretion of virulence-related proteins by Staphylococcus aureus
S. Shah et al.
LETTERS IN APPLIED MICROBIOLOGY (2008)
Bacterial pore-forming toxins: The (w)hole story?
M. R. Gonzalez et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2008)
Inhibition of S-aureus α-hemolysin and B-anthracis lethal toxin by β-cyclodextrin derivatives
Vladimir A. Karginov et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2007)
Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis
Carlos G. Grijalva et al.
LANCET (2007)
SILENCE: a new forward genetic technology
David J. Banks et al.
NATURE METHODS (2007)
Colicin biology
Eric Cascales et al.
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2007)
Targeting virulence: a new paradigm for antimicrobial therapy
Anne E. Clatworthy et al.
NATURE CHEMICAL BIOLOGY (2007)
Caspase-1 activation of lipid metabolic pathways in response to bacterial pore-forming toxins promotes cell survival
Laure Gurcel et al.
CELL (2006)
The mechanism of pore formation by bacterial toxins
SJ Tilley et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2006)
Construction and immunological characterization of a novel nontoxic protective pneumolysin mutant for use in future pneumococcal vaccines
LAS Kirkham et al.
INFECTION AND IMMUNITY (2006)
Resistance to antibiotics: Are we in the post-antibiotic era?
AJ Alanis
ARCHIVES OF MEDICAL RESEARCH (2005)
Cholesterol-dependent cytolysins, a family of versatile pore-forming toxins
RK Tweten
INFECTION AND IMMUNITY (2005)
Autophagy in cell death: an innocent convict?
B Levine et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
HIF-1α expression regulates the bactericidal capacity of phagocytes
C Peyssonnaux et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
An emergency response team for membrane repair
PL McNeil et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2005)
Pore-forming protein toxins: from structure to function
MW Parker et al.
PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY (2005)
Metalloproteinase inhibitors for the disintegrin-like metalloproteinases ADAM10 and ADAM17 that differentially block constitutive and phorbol ester-inducible shedding of cell surface molecules
A Ludwig et al.
COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING (2005)
Glycolipids as receptors for Bacillus thuringiensis crystal toxin
JS Griffitts et al.
SCIENCE (2005)
Protection against pneumococcal pneumonia in mice by monoclonal antibodies to pneumolysin
MD García-Suárez et al.
INFECTION AND IMMUNITY (2004)
Human CD59 is a receptor for the cholesterol-dependent cytolysin intermedilysin
KS Giddings et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2004)
Cyclodextrin-based pharmaceutics: Past, present and future
ME Davis et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
Characterisation of mouse monoclonal antibodies for pneumolysin:: fine epitope mapping and V gene usage
B Suárez-Alvarez et al.
IMMUNOLOGY LETTERS (2003)
Cryptic clues as to how water-soluble protein toxins form pores in membranes
MW Parker
TOXICON (2003)
Characterization of anthrolysin O, the Bacillus anthracis cholesterol-dependent cytolysin
JG Shannon et al.
INFECTION AND IMMUNITY (2003)
A conserved family of prolyl-4-hydroxylases that modify HIF
RK Bruick et al.
SCIENCE (2001)
Protection against Streptococcus pneumoniae elicited by immunization with pneumolysin and CbpA
AD Ogunniyi et al.
INFECTION AND IMMUNITY (2001)
Effect on polymorphonuclear cell function of a human- specific cytotoxin, intermedilysin, expressed by Streptococcus intermedius
MG Macey et al.
INFECTION AND IMMUNITY (2001)
Current perspectives on statins
DJ Maron et al.
CIRCULATION (2000)
分享论文
